Leading Innovation in the Life Sciences
New York Bio Connect aims to simplify and amplify the state and city’s life sciences ecosystem, organizing opportunities from Manhattan to Buffalo to position students, entrepreneurs, investors, policy makers, and established industry leaders for success.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
New report details how U.S. can maintain biotech competitiveness
A new report from the Reagan-Udall Foundation for the FDA, funded by BIO, warns that the United States is on the verge of losing its historic lead in drug development—its share of the global pipeline has slipped from 47% in 2013 to 36% in 2025 as China closes the gap. To stay competitive, the report…
Why a global health organization just placed a $10M bet on Buffalo
A University at Buffalo startup developing next-generation vaccine technology has secured up to $9.7 million from the Coalition for Epidemic Preparedness Innovations, recognition that its platform could play an important role in the rapid deployment of vaccines against emerging infectious diseases. The non-dilutive funding marks a significant milestone for POP Biotechnologies, positioning the Buffalo company…
FesariusTherapeutics Closes Oversubscribed $20M Series A, Led by Jefferson Life Sciences, and Backed by NY Ventures, and the American Society of Plastic Surgeons
FesariusTherapeutics, a commercial-stage medical technology company reimagining dermal repair, today announced the close of an oversubscribed $20 million Series A financing round. The round was anchored by Jefferson Life Sciences (JLS) and joined by Johnson & Johnson (through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc.), Empire State Development’s NY Ventures,…
Opinion: Local trade groups must support life sciences in these difficult times
NewYorkBIO CEO Jennifer Hawks Bland shares with Biospace that state and local trade groups have become essential to sustaining the U.S. life sciences industry as federal funding is cut and delayed and the policy environment shifts. With companies responding by laying off staff, moving operations abroad, or rethinking business models, she writes that local ecosystems…
New York State Invests Millions in New Biotech Initiative, with Focus on Neurodegenerative Diseases
New York Governor Kathy Hochul (D) signed the state’s annual budget into law, which includes $65 million for the Governor’s Bolstering Biotech Initiative. This new initiative reflects recommendations developed by the 2025 New York State Emerging Technology Advisory Board (ETAB) — co-chaired by Michael J. Fox Foundation CEO and Co-Founder Debi Brooks — to strengthen…
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
#2
NATIONAL R&D SPEND
100,000+
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.